US Stock MarketDetailed Quotes

EDIT Editas Medicine

Watchlist
  • 1.380
  • +0.150+12.20%
Close Feb 14 16:00 ET
  • 1.380
  • 0.0000.00%
Post 20:01 ET
113.92MMarket Cap-0.54P/E (TTM)

Editas Medicine Key Stats

Editas Medicine Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 640.250K--
--2024/Q4-- / 37.171M--
--2024/Q361.000K / 3.894M--
Aug 7, 20242024/Q2513.000K / 4.142M--
May 8, 20242024/Q11.135M / 7.296M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 640.250K--
--2024/Q4-- / 37.171M--
--2024/Q361.000K / 3.894M--
Aug 7, 20242024/Q2513.000K / 4.142M--
May 8, 20242024/Q11.135M / 7.296M--

Unlock Free Earnings Estimates

Editas Medicine Earnings Reports

Read more

Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 17, 2025

Hold

  • Buy

    28.57%
  • Hold

    57.14%
  • Sell

    14.29%

Price Target

No Data